IP Library Granted Patent US 7,337,005
Granted Patent B2
US 7,337,005 · App. 11/221,570 · Granted Feb 26, 2008

Methods for stimulating a nerve root ganglion

Assignee: Spinal Modulations, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,337,005
App. No.
11/221,570
Granted
Feb 26, 2008
Kind
B2
Abstract

Some embodiments of the present invention provide stimulation systems and components for selective stimulation and/or neuromodulation of one or more nerve root ganglia through implantation of an electrode on, in or around a nerve root ganglia. Some other embodiments of the present invention provide methods for selective neurostimulation of one or more dorsal root ganglia as well as techniques for applying neurostimulation to the spinal cord. Still other embodiments of the present invention provide stimulation systems and components for selective stimulation and/or neuromodulation of one or more nerve root ganglia through implantation of an electrode on, in or around a nerve root ganglia in combination with a pharmacological agent.

Claims (28)

1. A method of stimulating a nerve root ganglion, comprising:

implanting an electrode into the nerve root ganglion; and

activating the electrode to stimulate the nerve root ganglion, wherein the nerve root ganglion is a dorsal root ganglion.

2. The method according to claim 1 further comprising:

releasing a pharmacological agent from the electrode.

3. The method according to claim 2 wherein the releasing step is performed before the activating step.

4. The method according to claim 2 wherein the releasing step is performed after the activating step.

5. The method according to claim 2 wherein the releasing step is performed during the activation step.

6. The method according to claim 2 wherein the pharmacological agent is pharmacologically active during the activating step.

7. The method according to claim 2 wherein the pharmacological agent is db-cAMP.

8. The method according to claim 2 wherein releasing a pharmacological agent from an electrode comprises intraganglionic delivery of db-cAMP.

9. The method according to claim 1 wherein a portion of the electrode is coated with a pharmacological agent.

10. The method according to claim 9 wherein the pharmacological agent is selected from the group consisting of: anti-inflammatory agents, opiates, COX inhibitors, PGE2 inhibitors, and other suitable agents to prevent pathological pain changes after surgery.

11. The method according to claim 1 wherein implanting an electrode compnses:

forming an opening in a spinal dorsal root ganglion epinurium; and

passing the electrode through the opening.

12. The method according to claim 1 wherein implanting an electrode comprises:

forming an opening in a nerve root ganglion epinurium of a nerve root ganglion in the sympathetic nervous system; and

passing the electrode through the opening.

13. The method according to claim 1 fUrther comprising:

forming an opening in a portion of a spinal nerve root; and

passing the electrode through the opening.

14. The method according to claim 1 wherein the activating step further comprises coupling a programmable electrical signal to the electrode.

15. The method according to claim 1 wherein activating the electrode to stimulate comprises activating the electrode to stimulate neural tissue at an energy level below a level that will ablate the neural tissue being stimulated.

16. A method of stimulating a nerve root ganglion, comprising:

implanting an electrode into the nerve root ganglion; and

activating the electrode to stimulate the nerve root ganglion wherein implanting an electrode comprises implanting an electrode into a ganglion of the sympathetic nervous system and implanting another electrode into a spinal dorsal root ganglion.

17. The method according to claim 16 wherein the spinal dorsal root ganglion influences neural transmissions from the ganglion of the sympathetic nervous system when the spinal dorsal root ganglion is stimulated.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2023
From: ST. JUDE MEDICAL LUXEMBOURG HOLDINGS SMI S.A.R.L. ("SJM LUX SMI")
To: TC1 LLC
Reel/Frame 064903/0680 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2015
From: SPINAL MODULATION LLC
To: ST. JUDE MEDICAL LUXEMBOURG HOLDINGS SMI S.A.R.L. ("SJM LUX SMI")
Reel/Frame 037199/0142 →
CHANGE OF NAME Recorded Nov 20, 2015
From: SPINAL MODULATION, INC.
To: SPINAL MODULATION LLC
Reel/Frame 037150/0872 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2008
From: SPINAL MODULATION, INC.
To: KIM, DANIEL H.
Reel/Frame 021462/0438 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2008
From: KIM, DANIEL H.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 021462/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2005
From: KIM, DANIEL H.; IMRAN, MIR A.
To: SPINAL MODULATION, INC.
Reel/Frame 016789/0443 →
Continuity (2)
Provisional Application 6060835700 · Sep 8, 2004
Related Publication 20060052828A1 · Mar 9, 2006